The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

BXP BEXIMCO PHARMACEUTICALS LIMITED GDR (EACH REPR 1 ORD BDT10)(REGS)




Time/Date Code Headline Source Impact
07:00 24-Jul-2015 BXP Half Yearly Report RNS +5.13% Up
10:53 13-Jul-2015 BXP Payment of Cash Dividend RNS -0.84% Down
07:00 26-Jun-2015 BXP Stock Dividend Issued and Total Voting Rights RNS +3.84% Up
07:00 24-Jun-2015 BXP Beximco Pharma receives US FDA approval RNS +6.57% Up
07:00 15-Jun-2015 BXP AGM Statement RNS -
07:00 14-May-2015 BXP First Quarter Results RNS +9.17% Up
07:01 12-May-2015 BXP AGM Notification RNS +9.23% Up
07:00 11-May-2015 BXP Annual Financial Report RNS +8.84% Up
07:00 28-Apr-2015 BXP Notification of Preliminary Results and AGM RNS -3.75% Down
07:00 02-Feb-2015 BXP Beximco Pharma completes US FDA Audit RNS -1.37% Down
07:00 28-Jan-2015 BXP Enters into new Loan Agreement to fund expansion RNS -0.55% Down
12:42 19-Jan-2015 BXP Beximco Pharma commences export to Australia RNS +3.11% Up
07:00 12-Dec-2014 BXP Appointment of Nominated Adviser RNS -8.71% Down
07:00 24-Nov-2014 BXP Receives GMP Approval from Health Canada RNS +4.70% Up
07:00 03-Nov-2014 BXP Board Appointment RNS +2.36% Up
07:00 30-Oct-2014 BXP Financial Results for the Third Quarter of 2014 RNS +3.38% Up


Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank “ - “ next to the line indicating the RNS issue.

Market

Company Information
Updated Monthly
Company address 17 Dhanmondi R/A, Road No. 2, Dhaka, 1205, Bangladesh
Company website http://www.beximco-phar...
Market cap(in millions)* £ 64.65
Listing/Admission to trading 21 Oct 2005
Trading service -
Market -
Listing category -
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
03-Aug-15
FTSE index -
FTSE sector -
FTSE sub-sector -
Country of share register -
Segment -
MiFID Status -
Exchange market size -
SEDOL -
ISIN number -



BEXIMCO PHARMA share - news analysis